Babak Kosari, D.P.M., INC.
Babak Kosari, D.P.M., INC. was paid $895K by Medicaid between Jan 2018 and Dec 2024, across 16 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoBABAK KOSARI, D.P.M., INC.
NORTHRIDGE, CA 91325
NORTHRIDGE, CA 91325
33aNPI1720104227assigned 03/22/2007
33bProvider typeFoot & Ankle Surgery Podiatrist
28Total paid$895K
24GClaims35,810
24DCodes billed16
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Foot & Ankle Surgery Podiatrist providers in California
Rank by total paid#25 of 384
Median peer was paid$24K
This provider vs. median37×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,465 | $17K | |
| 2019 | 3,206 | $61K | |
| 2020 | 3,617 | $71K | |
| 2021 | 3,723 | $74K | |
| 2022 | 7,473 | $207K | |
| 2023 | 9,230 | $320K | |
| 2024incomplete | 7,096 | $144K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 10,180 | 9,196 | $249K |
| L3000 | Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each | 15% | 1,145 | 567 | $131K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 8,002 | 7,583 | $128K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 11% | 2,184 | 2,183 | $98K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6.1% | 2,002 | 2,001 | $55K |
| 11056 | 4.9% | 3,147 | 3,113 | $44K | |
| 11721 | 4.8% | 2,530 | 2,520 | $43K | |
| 20550 | 4.2% | 1,717 | 1,371 | $37K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 4.0% | 538 | 259 | $36K |
| 11750 | 2.7% | 539 | 387 | $24K | |
| 73630 | 2.4% | 1,358 | 1,010 | $22K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1.1% | 1,902 | 1,882 | $10K |
4 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKOSARI, BABAK (CEO)